China, Oct. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Efficacy and Safety of Denosumab in Treating Bone Metastases from Cancer'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134688
Registration Time: 2026/10/19
Type: Observational study
Primary Sponsor: The First Hospital of Hebei Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348318
Published by HT Digital Content Services with permission from Health Daily Digest....